A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani.

Slides:

Advertisements

Similar presentations

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Advertisements

A Propensity-matched Study of Lobectomy Versus Segmentectomy for Radiologically Pure Solid Small-sized Non-small Cell Lung Cancer Terumoto Koike 1, Seijiro.

The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.

Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,

A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.

1 Heart surgery in Norway 2008 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD

Norwegian register for general thoracic surgery.

King’s College Hospital, London, UK

Norwegian register for general thoracic surgery.

Brain imaging prior to lung cancer resection

Single IMA {Single Arterial}

Esophagectomy for cancer:

Lako S, Daka A, Nurka T, Dedej T, Memishaj S

Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.

Compassionate People World Class Care

Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum.

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2006 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.

Krdžalic Goran, Mušanović Nermin, Kešetović Amar

Department of Surgery, Siauliai Cancer Center, Lithuania

Prognosis of younger patients in non-small cell lung cancer

Relationship between the site of esophageal carcinoma and survival of patients with locally advanced disease Authors: Andrea Masarykova, Ingrid Zavacka,

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2007 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

In the name of God.

Laparoscopic vs Open Colonic Surgery: Long Term Survival

Fig. 3 Summary estimates of the relative risks for the different surgical techniques for late mortality. Comparing the two main techniques, EVR showed.

Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung

Results Results Introduction Objectives Conclusions

Background 8-29 % of patients with colon cancer present with partial or total obstruction (1) Emergency surgery is associated with up to 25% mortality.

Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Satya Shanbhag Waikato Cardiothoracic Unit

Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population- Based Study of 1686 Cases Åslaug Helland, MD, PhD, Steinar Solberg,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Low-Dose Steroid Therapy at an Early Phase of Postoperative Acute Respiratory Distress Syndrome Hyun-Sung Lee, MD, Jong Mog Lee, MD, Moon Soo Kim, MD,

Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy Hasan Fevzi Batirel, MD,

Surgical Treatment of Metachronous Second Primary Lung Cancer

Outcome of Esophagectomy for Cancer in Elderly Patients

Patient-Centered Management in Advanced Non-Small Cell Lung Cancer

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

The role of simultaneous resection of synchronous liver metastasis and primary colorectal cancer Samuel Lo Department of Surgery.

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Mark K Ferguson, MD, Amy G Lehman, BA The Annals of Thoracic Surgery

The Relationship Between Hospital Surgical Case Volumes and Mortality Rates in Pediatric Cardiac Surgery: A National Sample, 1988–2005 Karl F. Welke,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies Hon-Chi Suen, MBBS, Bryan F Meyers, MD, Tracey Guthrie, BSN, Mary.

Characteristics of Malignant Pleural Mesothelioma in Women

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Marc de Perrot, MD, Karen McRae, MD, Masaki.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

National data in surgery: LCCOP 2018(2016)

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Norwegian Association for Cardiothoracic Surgery

Surgical resection of metachronous liver metastases

Alexander H. Moskovitz, MD, Nabil P

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani. Short And Long-term Outcomes of Pneumonectomy For Lung Cancer: 15-Years Experience A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani. Department of Cardiothoracic Surgery, Castle Hill Hospital, Hull, United Kingdom Background: Surgery is the most important therapeutic modality for the treatment of locally advanced and centrally located lung cancer. Surgical outcomes are normally reported as 30-day or 90-day mortality or 5-year survival. However, 10-years survival is rarely mentioned in the national data or international studies. Methods: Patients included who underwent penumonectomy from January 1998 to February 2013, and their short and long-term outcomes were analysed till september2014. Thoracoscore was used to calculate the risk of in-hospital mortality. National Thoracic Surgery Activity & Outcomes Report 2011 by Society for cardiothoracic Surgery of Great Britain and Ireland demonstrated 6.5% mortality in pneumonectomy patients compare to 2 % in lobectomy for lung cancer and 7.9% vs. 2.4% mortality for non-lung cancer surgery respectively Result: 306-patients underwent pneumonectomy mainly for lung cancer. 79% were male, median age was 64-years (22-82years) and 24% were ≥ 70-years. Operative mortality was 4.5% while predicted mortality was 8%. However, operative mortality for cancer patients was 3.3% while reported national mortality for lung cancer is 6.5%. Only 2-patients died in hospital after pneumonectomy in the last 5 years. Half of the patients, who died in hospital, were ≥70-years while 29%(4-patients) died after urgent operation for non-malignant-disease. There was no in-hospital mortality in extra-pleural pneumonectomy (EPP) patients for malignant mesothelioma. Mean and median survival for pneumonectomy was 4.8 years (95% CI 4.1-5.4 years) and 2.2 years (95% CI 1.7-2.7 years) respectively. Overall 1, 2, 3, 5 and 10-year survival rates were 70%, 54%, 42%, 32% and 20%. Long-term survival was better in female, patients with age <70 years, in left pneumonectomy and for squamous-cell-lung-cancer patients. However, age > 70 years, right pneumonectomy and urgent surgery for non-malignant disease were emerged as risk factors. Conclusions: This retrospective single institutional study have shown that the mortality is 50% less than national mortality for pneumonectomy and significantly lower than that predicted by Thoracoscore. This confirms that pneumonectomy is still an effective and valuable modality in the treatment of advanced lung cancer with low operative mortality and good long-term survival especially in younger patients. It can be done safely with good short and long-term outcome by trained experienced surgeons.